Net Income After Tax Net income attributable to the Company’s shareholders for the second quarter of 2019 totaled RMB3,071.4 million (US$447.4 million), compared to RMB2,382.1 million and RMB2,106.5 million for the preceding quarter and the second quarter of 2018, respectively. Non-GAAP net...
Income Statement Balance Sheet Cash Flow Sec Filings Filing Date Filing Date Document Date Type Category Amended 02/13/2025 02/13/2025 N/A SC 13G/A Institutional Ownership * 02/03/2025 02/03/2025 02/03/2025 8-K Special Events 12/19/2024 ...
Advanced Charting 1D5D1M3M6MYTD1Y3YAllRange Dropdown $%Vol Volume: 256.45K65 Day Avg: 1.42M 18% vs Avg 1.7501Day Range1.8750 1.040452 Week Range33.1000 Your Watchlists Recently Viewed Tickers Income Statement Balance Sheet Cash Flow Sec Filings...
Any attempted assignment by a Party in violation of this Section shall be null and void ab initio. This Agreement shall bind and inure to the benefit of the Parties hereto and their respective successors and permitted assigns.30 Representations and Warranties 30.1 Good Standing. Provider represents...
The slightly lower effective tax rate for fiscal year 2021 was mainly due to reduced unrealized exchange losses.Net Income and Non-GAAP Net IncomeNet income attributable to the Company’s shareholders for fiscal year 2021 totaled RMB16,856.8 million (US$2,645.2 million), compared with RMB12,...
Business Development: AbbVie acquired Stemcentrx and its lead late-stage asset, rovalpituzumab tesirine (Rova-T), further strengthening AbbVie's oncology portfolio by providing a highly attractive platform in solid tumors. AbbVie also entered into a collaboration with Boehringer Ingelheim to develop...
Pretax Income Income Tax Tax Rate As reported $ 1,066 $ 262 24.6% One-time charges $ 36 $ 5 13.0% Excluding one-time charges $ 1,102 $ 267 24.2% Q10) What is your guidance for earnings per share from Continuing Operations for the fourth-quarter 2004? A10) For the first...
Zenas advanced obexelimab into Phase 3 clinical studies in the first quarter of 2023 and dosed their second patient in the second quarter of 2023. The Company received a development milestone in the form of additional preferred stock in Zenas with a fair value of $10.0 million. The Company ...
our ability to consummate or implement or realize synergies from our strategic initiatives and any consequences from our pursuit of our corporate strategy, including the proposed business combination with OMX AB, the transactions with Borse Dubai Limited and the Dubai International Financial Exchange and...
2016 and December 2, 2019 from the Department of the Treasury of the Commonwealth of Puerto Rico that the Plan, as written, qualifies under Section 1081.01(a) of the Puerto Rico Internal Revenue Code of 2011, as amended and, consequently, its enabling trust is exempt from local income tax....